Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Recurrence Risk Low For Women Who Survive Breast Cancer Five Years After Treatment, Study Says
http://www.medicalnewstoday.com/articles/118370.php
<BR />Women who survive breast cancer for at least five years after treatment have an 89% chance that they will not have a recurrence of the cancer after 10 years and an 81% chance after 15 years, according to a <A href="http://jnci.
Joint Symptoms More Likely For Some Breast Cancer Patients
http://www.medicalnewstoday.com/articles/118306.php
An article published in <i>The Lancet Oncology</i> reportsthat postmenopausal women with breast cancer who are on endocrinetreatment are likely to experience arthralgia and arthritis(joint symptoms) if they previously have used hormone replacementtherapy (HRT), received a hormone-receptor positive tumor diagnosis,undergone chemotherapy, received treatment with anastrozole versustamoxifen, or been obese.
Breakthrough's Comment On Research Suggesting A Combination Of Drug Treatments Could Stop Tumour Growth
http://www.medicalnewstoday.com/articles/118304.php
Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours.
----------------------------------------------
** CANCER / ONCOLOGY News **
Therapeutic Target ID'd For Deadly Childhood Muscle Cancer
http://www.medicalnewstoday.com/articles/118321.php
Curbing the activity of a substance called "platelet-derived growth factor receptor A" dramatically reduced aggressiveness of an often untreatable childhood muscle cancer in mice and cells, a new study from The University of Texas Health Science Center at San Antonio and partner institutions shows.
BioCurex Presents RECAF Results At International Cancer Congress
http://www.medicalnewstoday.com/articles/118307.php
BioCurex Inc. (OTCBB:BOCX) announced that the Congress Scientific Committee has accepted its presentation to the ISOBM annual meeting. BioCurex will present results obtained with its ELISA RECAF blood test for cancer at the 2008 assembly of the International Society of Oncology and Bio-Markers (ISOBM).
Breakthrough's Comment On Research Suggesting A Combination Of Drug Treatments Could Stop Tumour Growth
http://www.medicalnewstoday.com/articles/118304.php
Research by scientists at the University of Sheffield suggests that the combination of zoledronic acid (a drug used to prevent bone loss) and chemotherapy agent doxorubicin could stop the growth of breast cancer tumours.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Scientists Discover Major Genetic Cause Of Colorectal Cancer
http://www.medicalnewstoday.com/articles/118377.php
About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.
Colon Cancer Linked To Unequal Gene Activity
http://www.medicalnewstoday.com/articles/118320.php
Researchers here have discovered that a subtle difference in the activity of a pair of genes may be responsible for one of every 10 colon-cancer cases.The work, led by researchers with the Human Cancer Genetics Program at Ohio State University's Comprehensive Cancer Center, is the first to link this particular gene conclusively as a cause of colon cancer, and it may provide clinicians with a new way to identify people who are at high risk for disease.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Clinical Data Published In 'Science' Show Tumor Regressions In Relapsed Lymphoma Patients Treated With T Cell Engaging BiTE Antibody Blinatumomab
http://www.medicalnewstoday.com/articles/118310.php
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced publication of a Phase 1 clinical study(1) on its BiTE(R) antibody blinatumomab (MT103/MEDI-538) in this week's issue of Science.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Dendreon Initiates Second Of Two New Phase 2 Trials Of PROVENGE For Prostate Cancer
http://www.medicalnewstoday.com/articles/118312.php
Dendreon Corporation (Nasdaq: DNDN) announced that the Company has initiated its second of two new Phase 2 trials of PROVENGE(R) (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for the treatment of advanced prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment